Skip to content
About Us
Board of Directors
Management Team
Investors
Scientific Advisory Board
Careers
News
Conferences and Exhibitions
Products
Cyto-Mine®
Cyto-Cellect™ Probes
Research Instruments
ESI-Mine™
CellJet 3D Bioprinter
Specialist Chemicals
Microfluidic Hydrogel Kit
R&D Services
Applications
Antibody Discovery
Cell Line Development
Single Cell Dispensing
Cell Engineering and Synthetic Biology
Future Applications
Technology
Where to Buy
Resources
Product Information
Application Materials
Scientific Papers
Videos
How-To Videos
Blogs
Store
Service & Support
Contact Us
Sphere Fluidics and Geneva Biotech receive €1.6 million Eurostars genome editing grant.
Posted on
November 24, 2017
January 21, 2021
More information:
SF_PR_Eurostars Geneva Biotech_FINAL_27 11 27
#SphereFluidics is Highly Commended in SME 2017 National Business Awards for Business Innovation at Wembley Stadium in London, UK.
Sphere Fluidics Doubles its UK Lab and Office Space at Babraham Research Campus to enable company expansion.
